Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 68.7K | -- | 1.35% | +9.3K | 2026-06-30 |
| DNB Asset Management AS | 55.1K | -- | 1.08% | -- | 2026-06-30 |
| Longbow Finance SA | 16.7K | -- | 0.33% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 15.6K | -- | 0.31% | -1.8K | 2026-06-30 |
| CITADEL ADVISORS LLC | 15.4K | -- | 0.30% | -- | 2026-06-30 |
| BlackRock, Inc. | 13.4K | -- | 0.26% | +7.2K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 8.3K | -- | 0.16% | -- | 2026-06-30 |
| UBS Group AG | 4.9K | -- | 0.10% | -10.3K | 2026-06-30 |
| Steward Partners Investment Advisory, LLC | 2.0K | -- | 0.04% | -- | 2026-06-30 |
| US BANCORP \DE\ | 2.0K | -- | 0.04% | -- | 2026-06-30 |
